Pre-Application for the 2009 NIDA Avant-Garde Award Program for HIV/AIDS Research (X02)

The summary for the Pre-Application for the 2009 NIDA Avant-Garde Award Program for HIV/AIDS Research (X02) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Pre-Application for the 2009 NIDA Avant-Garde Award Program for HIV/AIDS Research (X02): Purpose. The NIDA Avant-Garde Award Program for HIV/AIDS Research is meant to complement NIDAs traditional investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose high-impact research that will open new avenues for prevention and treatment of HIV/AIDS among drug abusers. The purpose of this FOA is to solicit applications for the Avant-Garde Award. The X02 application will be reviewed by external reviewers to identify the most outstanding applications (applications from individuals of exceptional creativity who propose highly significant and innovative projects that are not appropriate for traditional grant mechanisms). Those investigators whose submissions are judged to be the most outstanding will be notified of the opportunity to submit full applications under RFA-DA-09-011. All awards will be made under RFA-DA-09-011. No awards will be made under this announcement. For additional information, consult the FAQs at http://nida.nih.gov/avgp2009/FAQ.pdf
Federal Grant Title: Pre-Application for the 2009 NIDA Avant-Garde Award Program for HIV/AIDS Research (X02)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-09-044
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: Feb 27, 2009
Original Application Deadline: Feb 27, 2009
Posted Date: Dec 12, 2008
Creation Date: Dec 12, 2008
Archive Date: Mar 30, 2009
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...
Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - C...
Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not ...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical ...
Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowe...
NINDS Program Project Grant (P01 Clinical Trial Optional)
Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial N...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com